QNRX

3.2802.35%
SL

Sally Lawlor

Chief Financial Officer

Ms. Sally Lawlor is Chief Financial Officer of Quoin Pharmaceuticals, Ltd. from August 18, 2025. Ms. Lawlor is an accomplished finance executive with experience in financial leadership roles in public and private companies as well as a Big Four accounting firm. In her most recent role at Sebela Pharmaceuticals, Ms. Lawlor managed financial reporting under U.S. GAAP and IFRS, oversaw global tax planning and compliance, as well as budgeting, forecasting and external audits. Prior to Sebela, she served in senior tax leadership positions at Aptiv Plc and spent over a decade at KPMG advising multinational clients, primarily in the pharmaceutical and technology sectors. Ms. Lawlor is a Fellow of Chartered Accountants Ireland and a member of the Irish Taxation Institute. She earned her Bachelor's degree in Law and German from University College Cork.

Positions